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Epidermolytic hyperkeratosis (EHK) is a blistering skin disease inherited as an autosomal-dominant trait. The
disease is caused by genetic defects of the epidermal keratin K1 or K10, leading to an impaired tonofilament
network of differentiating epidermal cells. Here, we describe for the first time a kindred with recessive inheri-
tance of EHK. Sequence analysis revealed a homozygous nonsense mutation of the KRT10 gene in the
affected family members, leading to a premature termination codon (p.Q434X ), whereas the clinically un-
affected consanguineous parents were both heterozygous carriers of the mutation. Semi-quantitative RT–
PCR and western blot analysis demonstrated degradation of the KRT10 transcript, resulting in complete
absence of keratin K10 protein in the epidermis and cultured keratinocytes of homozygous patients. This
K10 null mutation leads to a severe phenotype, clinically resembling autosomal-dominant EHK, but differing
in form and distribution of keratin aggregates on ultrastructural analysis. Strong induction of the wound-
healing keratins K6, K16 and K17 was found in the suprabasal epidermis, which are not able to compensate
for the lack of keratin 10. We demonstrate that a recessive mutation in KRT10 leading to a complete human
K10 knockout can cause EHK. Identification of the heterogeneity of this disorder has a major impact for the
accurate genetic counseling of patients and their families and also has implications for gene-therapy
approaches.
INTRODUCTION
Epidermolytic hyperkeratosis (EHK; MIM 113800), also
termed bullous congenital ichthyosiform erythroderma, is a
keratinization disorder with an incidence of approximately
one in 200 000 in the USA. The clinical phenotype of EHK
is characterized by erythema (redness of the skin) and wide-
spread formation of epidermal blisters developing with birth.
Later in life, bullous erythema is replaced by progressive
hyperkeratosis (thickening of the cornified layer of the
epidermis). The mode of inheritance is autosomal dominant,
but spontaneous mutations account for about half of the
cases. In general, heterozygous missense mutations can be
detected within highly conserved N-terminal and C-terminal
motifs of the a-helical rod domains of keratins K1 and K10
(reviewed in 1).
Keratins are members of the intermediate filament gene
family and are grouped into two classes, the acidic type I
(K9-K20 and Ha1-8) and the neutral-basic type II (K1-K8 and
Hb1-6) (2). Keratin intermediate filaments (KIFs) are heteropo-
lymeric structures composed of heterodimers of a type I keratin
and its specific type II keratin partner (3). In epithelial cells, ker-
atins are the building blocks of the KIF cytoskeleton, which pro-
vides stability to epithelial cells under conditions of mechanical
stress. The expression of keratin genes is highly regulated. In
the epidermis, KIF assembly is a dynamic process where
newly synthesized filaments are integrated into the existing
network. In the basal proliferative cell compartment, keratino-
cytes synthesize keratins K5 and K14 and defects in either
keratin are associated with the autosomal-dominant blistering
disease epidermolysis bullosa simplex (EBS) (4,5). Upon
commitment to terminal differentiation, K5 and K14 are
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downregulated and the differentiation-specific keratins K1 and
K10 are induced in the suprabasal layer of the epidermis.
Heterozygous point mutations of the keratin genes KRT1
and KRT10 in autosomal-dominant EHK result in an impaired
tonofilament network of terminally differentiating keratino-
cytes, leading to cytolysis within the suprabasal epidermis
(6–8). Ultrastructurally, this malfunction of the tonofilament
network in EHK is characterized by the formation of aggre-
gates of keratin filaments in suprabasal keratinocytes (9).
In this study, we present for the first time a kindred with a
recessive form of EHK. The affected family members carry
a homozygous nonsense mutation in KRT10, leading to com-
plete loss of epidermal K10 expression. The phenotype is
severe but not lethal. These findings are critical for the accu-
rate diagnosis and genetic counseling of EHK patients and
their families and have implications for gene-therapy
approaches for keratin disorders.
RESULTS
Clinical phenotype and pedigree of the family
The three-generation pedigree shows an autosomal recessive
mode of inheritance and contains two clinically affected
family members in the last generation and seven genetically
confirmed heterozygotes. The consanguineous parents (first
degree cousins) of the affected children as well as the other het-
erozygous family members are clinically unaffected (Fig. 1A).
Both affected siblings showed collodion skin and general-
ized erythroderma at birth (Fig. 1B, affected girl postpartal).
Collodion skin did not reappear after the first bathing. In the
first months after birth, both children developed erosions
after mild mechanical trauma and progressive ichthyosis. At
the time of examination, the affected siblings exhibited gener-
alized hyperkeratosis, which was pronounced on the big joints,
elbows and knee bends (Fig. 1C and E). The 8-year old boy
showed a conspicuous cobblestone morphology of the hyper-
keratosis in the neck area (Fig. 1D) and the 6-year old girl
displayed erythema and hyperkeratosis and additionally spon-
taneous erosions on the back (Fig. 1F). In both children,
palmoplantar sites were not affected.
Nonsense mutation in exon 6 of KRT10
Sequence analysis identified a homozygous base pair exchange
(CAA! TAA) at base pair position 1300 in exon 6 of KRT10
(c.1300C. T ) in both affected siblings. Both parents are hetero-
zygous carriers of the mutation. A common polymorphism could
be excluded by the absence of the mutation in 50 unrelated
control DNA samples. The mutation results in a premature ter-
mination codon (PTC) p.Q434X, 25 amino acid positions prior
to the end of the 2B domain ofK10. Figure 2A shows the respect-
ive part of the electropherogram and Figure 2B illustrates the
position of the PTC within the K10 protein.
KRT10 mRNA and K10 protein are absent in skin and
organotypic cell cultures of recessive EHK patients
In semi-quantitative RT–PCR of RNA isolated from cultured
keratinocytes, a KRT10 PCR product could be detected in the
heterozygous mother after 25 PCR cycles, whereas specific
signals in the affected homozygous children did not appear
even at 40 cycles, indicating a massive reduction of specific
KRT10 mRNA levels in homozygotes (Fig. 3).
Immunofluorescence analysis using two specific mono-
clonal mouse antibodies against keratin 10 (DE-K10 and
LH2) directed against the amino-terminus showed the
absence of K10 protein in the epidermis of the affected
family members (Fig. 4A). Western blot analysis of cyto-
skeletal preparations of organotypic co-cultures using the
same specific mouse monoclonal antibodies showed complete
absence of K10 protein in the affected patients. In the hetero-
zygous mother, a band of the expected size of 56.5 kDa could
be detected (Fig. 5).
Keratin expression in the absence of K10
When tissue samples of the affected individuals were analysed
by immunohistochemistry, profound changes in the expression
of epidermal keratins and terminal differentiation markers
could be observed. The distribution and expression of K1
protein, the natural type II partner keratin of K10, seemed to
be unaltered. The acanthotic epidermis of recessive EHK
patients showed a strong and equal basal and suprabasal stain-
ing, whereas in a control individual as well as in the heterozy-
gous mother, K14 expression was predominantly found in the
basal layer and decreased suprabasally. The proliferative ker-
atins K6, K16 and K17 were strongly and evenly expressed in
all suprabasal cell layers of the patients’ epidermis, whereas
only minimal staining could be detected in the control. Inter-
estingly, the sites of cytolysis showed a correlation with the
maximal K6/K16 and K17 expression. Both epidermal differ-
entiation markers filaggrin and, to a lesser extent, loricrin
showed increased staining in the granular and corneal layers
of the patients’ epidermis (Fig. 4A). Immunohistochemical
analysis of a skin biopsy from the mother showed an
expression pattern identical to the control.
Ultrastructural alterations of the epidermis in
recessive EHK
Histopathologic examination of skin biopsies of the affected
children revealed hyperkeratosis (increased keratinization
which leads to the production of a thickened stratum
corneum composed of anucleate squames), acanthosis
(increase in keratinocyte population of the spinous layer
with thickening of the epidermis) and papillomatosis [increase
in keratinocytes with formation of projections (papillae) from
the surface of skin]. The suprabasal epidermal layers showed
vacuolar degeneration of the keratinocytes and, within the
thickened granular layer, coarse keratohyaline granules were
evident (Fig. 4B).
Electron microscopy in low magnification (Fig. 6A) showed
a cell morphology similar to cases of autosomal-dominant
EHK. Cytolysis was found to occur within the suprabasal
layers of the epidermis. The ultrastructure of basal keratino-
cytes did not show pathologic changes. As soon as keratino-
cytes entered into terminal differentiation in suprabasal
epidermal layers, increasing numbers of loose and irregularly
shaped electrodense clumps occurred. These clumps are a
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Figure 1. (A) Pedigree of the family. Genomic DNA samples were studied from the members marked with an asterisk. Carrier status is shown with respect to the
mutation delineated in this study. (B–F) Clinical phenotype of the patients.
Human Molecular Genetics, 2006, Vol. 15, No. 7 1135
morphological hallmark of dominant EHK and correspond to
aggregates of KIFs (9). Owing to the collapse of the defective
cytoskeleton, the cytoplasm had a ‘vacant’, electron-lucent
aspect in some areas. The nuclei tended to be located to the
periphery of the cells. Keratohyalin granules were increased
in number and size and had a significantly coarser structure
than in normal epidermis. The structure and number of desmo-
somes appeared to be normal.
In higher magnifications (Fig. 6B and C), sparse keratin fila-
ments were found within the suprabasal epidermal layers
forming thin and isolated bundles. The keratin clumps were
associated partially with desmosomal plaques. Perinuclear
shells, as often observed in autosomal-dominant EHK patients,
were absent. Noteworthy, the keratin clumps in our patients
showed a nearly homogenous, amorphous structure. This is
in contrast to the keratin clumps in autosomal-dominant
EHK that regularly maintain a filamentous, thready aspect.
In the heterozygous mother, no ultrastructural abnormalities
of the epidermal keratinocytes could be detected in electron
microscopy (data not shown).
DISCUSSION
Until now, EHK has been considered a dominantly inherited
condition or due to the occurrence of dominant spontaneous
mutations. In dominant keratin skin disorders, keratin mis-
sense mutations act in a dominant negative fashion, as
mutated keratins perturb filament network formation after
incorporation. It has been shown that even small amounts of
mutated keratin can compromise the physical integrity of the
entire KIF network (10). The dominant negative effect of
keratin mutations is illustrated by the formation of keratin
aggregates that are grouped around the nucleus, visible upon
ultrastructural examination. It has been shown that these
keratin clumps contain the respective keratin pairs that
are specific for the state of differentiation, i.e. K5/K14 in the
basal compartment in EBS and K1/K10 in the suprabasal
layers of the epidermis in EHK (9).
We now report for the first time a kindred with a recessive
form of EHK. The affected individuals were found to be
homozygous for the nonsense mutation p.Q434X in the 2B
domain of K10, leading to a premature stop codon, whereas
the unaffected parents were heterozygous carriers of the
mutation. On the basis of the position of the premature stop
codon, a truncated K10 gene product of 40 kDa might be
expected to be generated (Fig. 2B). As previously demon-
strated in a mouse model expressing a truncated K10
peptide (11), the applied K10 antibodies LH2 and
DE-K10 are directed against the amino-terminal part of the
K10 protein and are able to recognize a truncated gene
product comprising 230 amino-terminal residues of K10.
Immunoblot analysis with the respective antibodies in the
Figure 2. (A) Part of the sequence of exon 6 showing the homozygous
mutation p.Q434X in the affected children. (B) Schematic presentation
illustrating the position of the PTC within the K10 protein.
Figure 3. Semi-quantitative RT–PCR of KRT10 mRNA in co-cultures of the
affected family members (2,3,5,6) and their mother (1,4) showing complete
absence of KRT10 mRNA levels in the homozygous patients. KRT10 PCR
products were loaded in lanes 1–3 and s26 PCR products in lanes 4–6.
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affected children failed to detect K10 protein, and the exist-
ence of a truncated K10 gene product could therefore be
excluded. To test whether the homozygous stop codon
causes decay at the RNA level, we conducted semi-
quantitative PCR on RNA isolated from cultured keratinocytes
and did not detect any specific KRT10 mRNA in the affected
homozygous children. These data indicate that the mutation
leads to instability and degradation of the mutant transcript
and homozygous patients represent a complete human knock-
out of the KRT10 gene. The heterozygous parents have no
abnormal phenotype, indicating that the remaining healthy
allele fully compensates for the loss of the mutated allele.
The mutation represents to our knowledge the first nonsense
mutation within a human suprabasal keratin.
Heterozygous nonsense mutations resulting in PTCs in the
2B domain of K5 or K14 have been found in autosomal-
dominant EBS [K5:p.K472X (12); K5:p.E477X (13); K14:
p.E411X (14)]. These mutations do not lead to mRNA
Figure 4. (A) Immunohistology of various epidermal keratins and differentiation markers showing the absence of epidermal K10 protein, persistence of K14
protein in suprabasal cell layers and strong suprabasal induction of the hyperproliferative keratins K6, K16 and K17 in the affected patient. Filaggrin and loricrin
are strongly induced in the granular epidermal layers. (B) Light microscopy showing hyperkeratosis, hypergranulosis, acanthosis and vacuolar degeneration of
the keratinocytes in the suprabasal layers (paraffin section, hematoxylin and eosin stain, high powered field).
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degradation and result in stable truncated gene products exert-
ing a dominant negative effect on the keratin cytoskeleton. In
contrast, it has been shown in an israelic case of EBS that the
mutation p.Q396X in the 2B domain of K14 results in KRT14
haploinsufficiency (15). An explanation for why K14:p.Q396X
and, the here described nonsense mutation, K10:p.Q434X lead
to transcript decay is provided by recent studies on the mech-
anism of nonsense-mediated RNA decay (NMD): NMD is
linked to a splicing-dependent deposition of a protein
complex close to each exon–exon junction. This so-called
exon-junction complex (EJC) plays a pivotal role in anchoring
the NMD specific factors upf2 and upf3 to the mRNA. Trans-
lating ribosomes displace the EJCs from the open-reading
frame during the ‘pioneer’ round of cytoplasmic translation
which prevents NMD. If, however, the mRNA contains a
PTC located more than a certain range upstream of at least
one EJC, complex components downstream of the PTC will
remain on the mRNA, thereby triggering NMD (reviewed in
16). It has been shown in the beta-globin gene that PTCs
50–55 nt upstream to the 30-most exon–exon junction or
downstream of this junction are not targeted by NMD (17).
This distance seems to vary in different genes, as a nonsense
codon as close as eight nucleotides from the last downstream
intron of the TCR-b gene still triggers mRNA decay (18). All
nonsense mutations in autosomal-dominant EBS reported so
far are located less than 92 nt upstream of the 30-most
exon–exon junction, whereas this distance is 476 nt in
K10:p.Q434X and 274 nt in K14:p.Q396X. On the basis of
these data, we suggest that in keratin genes, only PTCs
located at least 93 nucleotides upstream to the 30-most intron
can be targeted by NMD.
In contrast to our patients with recessive EHK, patients with
recessive EBS, which is generally caused by homozygous
nonsense mutations of K14, do not exhibit keratin clumping
in the basal epidermal layers. In these patients, only a very
sparse filament network of ‘wispy’ filaments could be demon-
strated at the ultrastructural level (19). This raises the question
why these two closely related disorders show such profound
ultrastructural differences.
In recessive EBS, keratin K15, which is normally expressed
in very low levels in basal keratinocytes, is upregulated to
compensate for the absent K14. However, K5 and K15 are
apparently not able to assemble into tonofilament bundles
and the presence of this very sparse keratin network is not suf-
ficient to impart mechanical strength to these cells (19,20).
The distinctive K5/K15 protofilaments were also observed in
a K14 knockout mouse model (21). In the absence of K14,
K15 is able to build a bona fide, but ultrastructurally distinct,
network with K5. In tissues with higher levels of K15 than
K14 such as neonatal esophagus, KIF networks appear
unchanged as a consequence of K14 ablation. Thus, it was
concluded that K5 has two natural partners, K14 and K15.
However, in epidermis, the K5/K15 network is obviously
not sufficient to compensate for the more robust K5/K14
network (21). In recessive EBS, upregulation of other type I
keratins was not found, precluding formation of atypical
heterodimers of K5 with K16 or K17.
In the human K10 knockout, ultrastructural analysis showed
thin and isolated bundles of keratin filaments within the supra-
basal layers. As in vivo, K10 (type I keratin) forms obligate
heterodimers with K1 (type II keratin), it was of interest to
study upregulation of alternative type I keratins in the
absence of K10. The formation of keratin aggregates in the
absence of mutated keratin K10 protein suggests a formation
of instable atypical heterodimers between residual K1 and
another type I keratin such as keratin K16 or K17, which
were found to be strongly induced in addition to keratin 6 in
the suprabasal layers of our patients. Generally, these ‘hyper-
proliferative’ keratins are not expressed in normal interfollicu-
lar epidermis and restricted to the outer root sheet of the hair
follicle (22). In wound healing and hyperproliferative pro-
cesses, these keratins are strongly induced. However, keratin
K6/K16 heterodimers form relatively poor intermediate fila-
ments when compared with those built up from keratins con-
stitutively expressed in the epidermis (23,24). The amorphous
structure of the keratin aggregates in recessive EHK might
indicate the incapability of these atypical heterodimers to
form higher order structures as keratin filaments or protofila-
ments. Particular qualities of this keratin pair might therefore
additionally contribute to skin fragility and cytolysis in
recessive EHK. This hypothesis is supported by the finding
that the sites of cytolysis show a correlation with the
maximal K6/16 and K17 expression in the homozygous
patients (Fig. 4).
Interestingly, K10 null mice which had been generated by
targeted inactivation of the keratin 10 gene show a very mild
phenotype (25). The basal keratins K5, K14 and K15
persisted suprabasally and it was postulated that in this
mouse model, the lack of K10 is compensated by decreased
proteolysis of the basal keratins K5 and K14 and their per-
sistence in suprabasal epidermal layers. Ultrastructurally,
keratin aggregates were found and shown to consist of
residual K1, which formed atypical heterodimers with K14.
Despite of the complete lack of K10 protein in neonatal
mice, an intact epidermis developed without signs of
increased fragility or cytolysis (25,26). Persistence of K14
expression in suprabasal layers could also be demonstrated
in the human K10 knockout, but obviously basal keratins
are not able to compensate for the loss of keratin K10 as
in the K10 null mouse model.
In a recent description of an autosomal recessive epidermoly-
tic ichthyosis in an extended pedigree of Norfolk terrier dogs,
Figure 5. Western blot analysis of cytoskeletal preparations of co-cultured
keratinocytes of the mother þ/2, the affected children 2/2 and an unrelated
control þ/þ showing the absence of K10 protein in the affected children.
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which is caused by a splice-site mutation in the canine KRT10
gene, keratin clumps were also observed upon ultrastructural
analysis (27). Homozygotes showed a mild phenotype after
birth, whereas heterozygotes were clinically normal. As no
keratin 10 protein was detected in the homozygous dogs, it is
tempting to speculate that a similar pathogenetic mechanism
takes place to that in the human disease. Moreover, the milder
phenotype in mouse and canine when compared with human
recessive EHK might be explained by additional stability
against mechanical stress provided by pelage hair.
Our findings have implications for gene-therapy approaches
in both dominant and recessive EHK: recessive disorders can
potentially be cured by delivery of a wild-type copy of the
aberrant gene. We have demonstrated in recessive EHK that
the heterozygous family members maintain a normal clinical
phenotype with a single copy of the KRT10 gene. Thus, intro-
duction of a single copy of the normal KRT10 gene should
restore a normal filament network in the homozygous affected
individuals. That one wildtype copy of K10 is sufficient to
maintain normal KIF function was also demonstrated in a
mouse model for the dominant form of EHK (28). Reduced
expression of the mutant K10 allele in this mouse was associ-
ated with a very mild phenotype and maintenance of normal
KIF function. In line with these data, this study provides
further evidence that in keratin disorders, improvement of
the phenotype may be achieved by partial suppression of the
mutant allele or overexpression of the normal allele.
Gene-therapy approaches altering the ratio of wild-type to
mutant protein should therefore be sufficient to restore the
epidermis to normal function.
Identification of the heterogeneous mode of inheritance of
EHK has a major impact for the accurate genetic counsel-
ing: so far, the risk of a second affected child in clinically
unaffected parents has been regarded to be only slightly
increased by the possibility of a parental mosaicism. Now,
careful exploration of the family pedigree has to be per-
formed to exclude parental consanguinity and a recessive
inheritance.
MATERIALS AND METHODS
Sources of material
Skin biopsy specimenswere taken by excision biopsy under local
anesthesia from the affected children and their mother, with
informed consent. The samples were taken from left thigh and
from left hip. After excision, skin samples were subdivided for
tissue culture, EM analysis and immunofluorescence analysis.
Blood samples were taken from all available family members
(marked by an asterisk in Fig. 1A) for extraction of DNA.
Mutation detection
Genomic DNA isolated from EDTA blood samples was used to
amplify exons 1–7 of KRT10 by PCR using exon-specific
primer pairs (data not shown). Primers for amplification of
exon 6 were 50-CAT ACT CAA CTG AAC AAG GAA GTC
ACT-30 and 50-CTG TAC TCTACCCTC TCT CCTCCC T-30.
An aliquot of 50 ml reaction solution containing 250 ng
DNA, 200 nM of each primer, 200 mM of each dNTP, 5 ml
BioTherm buffer (Natutec, Frankfurt, Germany) was initially
denaturated at 948C for 2 min, followed by 40 cycles of 45 s
at 948C, 45 s at 608C and 1 min at 728C, followed by a
7 min final extension step at 728C. After pre-treatment,
according to the manufacturer’s protocol with exonuclease I
(Amersham Biosciences Europe, Freiburg, Germany) and
shrimp alkaline phosphatase (USB, Cleveland, OH, USA) to
eliminate remaining oligonucleotides and dNTPs, the PCR
products were directly sequenced on a ABI PrismTM 377
DNA Sequencer (Applied Biosystems, Foster City, CA,
USA) applying the Taq FS BigDye-Terminator cycle sequen-
cing method. The same forward primer as in PCR was used in
the sequencing reaction.
Light microscopy and electron microscopy
Hematoxylin and eosin-stained paraffin sections were exam-
ined for routine light microscopy. For electron microscopy,
Figure 6. Ultrastructural analysis of skin biopsies of the affected children (A–C) showing coarse keratohyaline granules (KHG) and keratin clumping (KC) in
suprabasal keratinocytes. N, nucleus; D, desmosome. Bars: (A) 10 mm; (B and C) 20 mm.
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skin samples fixed in cacodylate-buffered 3% glutaraldehyde
and postfixed in 1% OsO4 solution, dehydrated in graded
ethanol solutions and embedded in gycidether 100 (formerly
Epon 812). Ultrathin sections were investigated using a
Philips EM 400 electron microscope.
Immunofluorescence analysis
Immunoreactivities (IRs) against epidermal keratins and filag-
grin were analysed using specific mouse-anti-human mono-
clonal antibodies. Antibodies against keratins K1 (LHK1),
K6 (LHK6B), K10 (LH2), K14 (LL001), K16 (LL025) and
K17 (E3) were a generous gift of Irene Leigh, Department
of Dermatology, Queen Mary and St Bartholomew School
of Medicine, London. Another monoclonal antibody to K10
Ab-2 (DE-K10) was purchased from Dianova, Hamburg,
Germany. The filaggrin antibody Ab-1 (FLG01) was pur-
chased from Neomarkers, Westinghouse, Fremont, USA.
The secondary Alexa Fluor 488 goat-anti-mouse antibody
was purchased from Molecular Probes Europe, Leiden, the
Netherlands. For immunofluorescence analysis of loricrin, a
polyclonal rabbit-anti-mouse antibody AF62 was used
(Covance, Berkeley, CA, USA). The secondary Alexa fluor
488 goat-anti-rabbit antibody was purchased from Dako
(DAKO, Hamburg, Germany). Sections of 5 mm were cut on
a cryostat microtome (Microm HM560) and placed on electro-
statically charged slides (Superfrost plus, BDH). Frozen sec-
tions were dried and fixed in acetone for 10 min.
Non-specific binding was blocked with 10% dilution of
normal goat serum in PBS for 1 h. Sections were incubated
with undiluted antibodies K1, K10, K14, K6, K16, K17, a
1:50 dilution of the filaggrin antibody and a 1:2500 dilution
of the loricrin antibody (all in 0.2% fish skin gelatine) over-
night at 48C. Slides were washed twice in phosphate-buffered
saline (PBS; pH 7.6). The secondary goat-anti-mouse antibody
was applied in a dilution of 1:200 and the secondary
goat-anti-rabbit antibody in dilution of 1:500 in 0.2% fish
skin gelatine at room temperature for 45 min. Sections were
again washed twice in PBS before counterstaining with propi-
dium iodide 1:100 for 10 min. After a further washing step,
sections were fixed with 4% formaldehyde solution for
5 min and covered with gelvatol. Immunoreactivity was visu-
alized on a Nikon Eclipse E800 fluorescence microscope.
Control sections treated without primary antibody were
devoid of IR.
Organotypic co-culture
Skin specimens were obtained from the homozygous family
members and their heterozygous mother. Human keratinocytes
were explanted and cultured for three passages on 3T3 fibroblast
feeders as described previously (29). Fibroblasts were isolated
from the dermis using collagenase I and cultured in Dulbecco’s
modified eagle medium (DMEM)þ 10% fetal calf serum (FCS).
Later, keratinocytes and fibroblasts were co-cultured inNunc cell
culture inserts (Nunc, Roskilde, Denmark). Fibroblasts were
embedded in 3 ml collagen lattices (rat tail collagen I, BD Bio-
sciences, Bedford, MA, USA) at a density of 1.5  106 cells
per ml. After culture in DMEMþ 10% FCS medium for 6
days, medium was changed to a keratinocyte growth medium
containing 5% FCS and on the following day 250 000 kerati-
nocytes were seeded onto the gel. Seven days later, the
co-culture system was lifted to the air–liquid interface and
cultured for additional 10 days in the presence of serum-free
keratinocyte growth medium.
Semi-quantitative RT–PCR
Co-cultured cells were homogenized using a mixer mill
(MM300, Retsch, Haan, Germany) and RNA was prepared
using the RNeasy Total RNA Kit (Qiagen, Du¨sseldorf,
Germany). An aliquot of 1 mg of poly(A)RNA was primed
with Oligo-dT and reverse transcribed in the presence of
RNAsin (Boehringer, Mannheim, Germany) using the Omni-
Script RT Kit (Qiagen, Du¨sseldorf, Germany). A 290 bp frag-
ment of KRT10 cDNA was amplified using a forward primer
from exon 4, 50-CCT TCG AAA TGT GTC CAC TGG-30,
and a reverse primer from exon 6, 50-CAG GGA TTG TTT
CAA GGC CA-30. Primers were generated using Primer
Express software (Applied Biosystems, Foster City, CA,
USA). The reverse primer was designed to span an intron–
exon boundary to prevent amplification of genomic DNA.
Specific primers were used for amplification of a 374 bp frag-
ment of ribosomal S26 cDNA (30) to normalize mRNA levels.
Amplification was carried out with 1 ml of the RT product in a
final volume of 50 ml for 40 cycles using the same PCR pro-
tocol as for mutation analysis. At cycles 25, 30, 35 and 40,
5 ml of the PCR product was taken out of the reaction tube.
After PCR amplification, these 5 ml aliquots were subjected
to electrophoresis on a 1.5% agarose gel. Ethidium bromide
(0.5 mg/ml) was used to visualize the PCR fragments under
ultraviolet light.
SDS–PAGE and western blot analysis
After organotypic co-culture, the epithelium was separated from
the underlying collagen lattice using fine watchmaker forceps
and cytoskeletal preparations were obtained as described (31).
One-dimensional SDS–PAGE of keratin preparations was per-
formed according to the method of Laemmli et al. (32). The pro-
teins were electrotransferred to nitrocellulose membranes
(Amersham, Hybond-ECL) according to the method of Towbin
et al. (33). Membranes were blocked in 5% non-fat milk
powder in Tris-buffered saline with 0.1% Tween-20. The
primary antibody LH2 was diluted 1:100. For detection, we
used a horse radish peroxidase-conjugated rabbit anti-mouse
antibody 1:600 (DakoCytomation, Glostrup, Denmark).
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